GlassScriptPhysician profile
Sunil M Thadani
NPI 1790951986
$3,106.99
in general payments reported to CMS, 2019-2025
25 companies · $688 in 2025
The $688 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $183 · 2021: $228 · 2022: $359 · 2023: $504 · 2024: $1,040 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689 · Travel and Lodging: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.25 |
| Travel and Lodging | $542.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,313.01 | 2019-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Novartis Pharmaceuticals Corporation | $198.07 | 2021-2023 | |
| Abbvie INC. | $197.37 | 2022-2025 | Durysta |
| Oyster Point Pharma, INC. | $168.29 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $166.40 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $147.66 | 2022-2025 | Miebo, Vyzulta, Prolensa |
| Tarsus Pharmaceuticals, INC. | $140.42 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $99.57 | 2019-2025 | Oxervate |
| Glaukos Corporation | $96.50 | 2024-2025 | Idosetr, Ce-Marked Kxla System |
| Allergan, INC. | $87.35 | 2020-2022 | |
| Harrow Eye, LLC | $82.72 | 2024-2025 | Vevye, Iheezo |
| Biotissue Holdings INC. | $51.49 | 2025 | |
| Rxsight INC | $50.58 | 2021-2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Eyevance Pharmaceuticals LLC | $44.56 | 2023 | Flarex |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $30.72 | 2023-2024 | Tecnis Simplicity, Amo Phaco Needle |
| Boston Scientific Corporation | $24.85 | 2022 | |
| Mallinckrodt Hospital Products INC. | $24.79 | 2022 | |
| Eyepoint US, INC. | $24.59 | 2020 | |
| Lensar, INC. | $24.51 | 2024 | Lensar Laser System |
| Aerie Pharmaceuticals, INC. | $22.57 | 2021 | |
| Shire North American Group INC | $22.33 | 2019 | |
| Kala Pharmaceuticals, INC. | $19.49 | 2019 | |
| Ocular Therapeutix, INC. | $17.03 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Thadani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.